Sheel Biotech IPO

Incorporated in 1991, Sheel Biotech is engaged in growing, developing, processing, and supplying plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. The company has an R&D laboratory with a production capacity of 1 crore planting materials annually. In FY25, 90.5% of procurement was domestic, while the rest came from imports of "BLUE RIBBON" 2L pots from the Netherlands. It has completed 59 major projects with a cumulative contract value exceeding ₹150 crore across various segments and operates 12 ongoing projects with a total contract value exceeding ₹30 crore, expected to be completed by 2025-27. The company operates through 5 segments, with the landscaping and planting segment contributing 34.48% of revenue, followed by greenhouse and packhouse at 27.95%. Meanwhile, government tenders contributed 56.6% of revenue in FY25.